These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6744346)

  • 1. Hypersensitivity reactions induced by etoposide.
    O'Dwyer PJ; Weiss RB
    Cancer Treat Rep; 1984; 68(7-8):959-61. PubMed ID: 6744346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide-induced hypersensitivity reactions. Report of two cases.
    Tucci E; Pirtoli L
    Chemioterapia; 1985 Dec; 4(6):460-2. PubMed ID: 3830414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Collier K; Schink C; Young AM; How K; Seckl M; Savage P
    J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
    Hayes FA; Abromowitch M; Green AA
    Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to etoposide. A report of three cases and review of the literature.
    de Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M
    Am J Clin Oncol; 1994 Oct; 17(5):387-9. PubMed ID: 8092107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etoposide in the treatment of recurrent malignant lymphoma].
    Háber J; Klener P
    Vnitr Lek; 1986 Apr; 32(4):379-85. PubMed ID: 3727425
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia.
    Kellie SJ; Crist WM; Pui CH; Crone ME; Fairclough DL; Rodman JH; Rivera GK
    Cancer; 1991 Feb; 67(4):1070-5. PubMed ID: 1991254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
    Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
    Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of etoposide in the treatment of esophageal carcinoma.
    Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
    Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
    [No Abstract]   [Full Text] [Related]  

  • 10. Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
    Konits PH; Van Echo DA; Aisner J; Morris D; Wiernik PH
    Am J Clin Oncol; 1982 Oct; 5(5):515-9. PubMed ID: 6758569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to etoposide phosphate.
    Sambasivan K; Mahmoud S; Kokache A; Seckl M; Savage P
    J Oncol Pharm Pract; 2014 Apr; 20(2):158-60. PubMed ID: 23740378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Delgado G
    Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
    [No Abstract]   [Full Text] [Related]  

  • 13. Etoposide--an effective single drug for treating bronchogenic carcinoma.
    Anderson G; Peel ET; Cheong CM; Broderick NJ
    Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypersensitivity reactions to etoposide.
    Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH
    Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin-induced hyperpigmentation and hypersensitivity reactions to etoposide and vinblastine in a child with endodermal sinus tumor.
    Mutafoğlu-Uysal K; Sarialioğlu F; Olgun N
    Turk J Pediatr; 2001; 43(2):172-4. PubMed ID: 11432501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etoposide desensitization. A case report].
    Alvarez Cardona A; Hernández Nieto L; Pérez Gómez M; Pedroza Meléndez A; Huerta López JG
    Rev Alerg Mex; 2010; 57(1):33-6. PubMed ID: 20857627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of etoposide in advanced prostate cancer.
    Trump DL; Loprinzi CL
    Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II clinical trial of VP-16-213 in ovarian cancer.
    Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
    Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome associated with etoposide therapy.
    Jameson CH; Solanki DL
    Cancer Treat Rep; 1983 Nov; 67(11):1050-1. PubMed ID: 6640556
    [No Abstract]   [Full Text] [Related]  

  • 20. Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
    Pringle NR; Gilbar PJ; Grewal GD
    J Oncol Pharm Pract; 2022 Jun; 28(4):1019-1023. PubMed ID: 35037804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.